Your browser doesn't support javascript.
loading
Duration of dual anti-platelet therapy following drug eluting stents: Less Is More?
Bang, Vigyan V; Levy, Michael S.
Afiliación
  • Bang VV; Lahey Hospital and Medical Center, Burlington, Massachusetts.
  • Levy MS; Lahey Hospital and Medical Center, Burlington, Massachusetts.
Catheter Cardiovasc Interv ; 87(4): 733-4, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26994982
ABSTRACT
This meta-analysis suggests that abbreviated DAPT (<6 months) could be considered in patients undergoing PCI with current generation drug eluting stents (DES). Extended DAPT strategy (>1 year) may be appropriate in those patients in whom prevention of stent and non-stent-related coronary events are likely to offset the bleeding complications. Additional randomized trials are needed to evaluate the optimum duration of DAPT in patients with the latest generation DES and current antiplatelet drugs.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Stents Liberadores de Fármacos / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Catheter Cardiovasc Interv Asunto de la revista: CARDIOLOGIA Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Stents Liberadores de Fármacos / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Catheter Cardiovasc Interv Asunto de la revista: CARDIOLOGIA Año: 2016 Tipo del documento: Article